Smart4COV19/Telemedicine - Smart Integrated Devices for Telemedicine to Combat COVID-19 Toward New Resilience City
Published October 21, 2022 | Version v1
Conference paper Open

IMPACT OF AIR POLLUTION ON COV-19 CONTAMINATION IN SOFIA FOR THE PERIOD 2020-2022

Authors/Creators

  • 1. ROR icon Space Research and Technology Institute

Contributors

Project leader:

  • 1. ROR icon Space Research and Technology Institute

Description

EN: In this paper we present the results of comparison between air pollution over Sofia city and numbers of new and active COV-19 cases. Air pollution measurements are on the base of Sentinel 5P data and 5 ground stations (AIS), based in Sofia city. Results show a good compliance between air pollution level and COV-19 cases.

 

BG: В тази статия представяме резултатите от сравнението между замърсяването на въздуха над град София и броя на новите и активни случаи на COV-19. Измерванията на замърсяването на въздуха са на базата на данни от Sentinel 5P и 5 наземни станции (AIS), базирани в град София. Резултатите показват добро съответствие между нивото на замърсяване на въздуха и случаите на COV-19.

Files

9_Dimitrova.pdf

Files (1.0 MB)

Name Size Download all
md5:f7326c151c34d741deeee88c6b3735ba
1.0 MB Preview Download

Additional details

Additional titles

Alternative title (Bulgarian)
ВЛИЯНИЕ НА АТМОСФЕРНОТО ЗАМЪРСЯВАНЕ ВЪРХУ COV-19 ЗАБОЛЕВАЕМОСТТА В СОФИЯ ЗА ПЕРИОДА 2020-2022

Identifiers

ISSN
2603-3313

Funding

Bulgarian Science Fund
Smart Integrated Devices For Telemedicine to Combat COVID-19 Toward New Resilience City - Smart4COV19/ Telemed КП-06-Д002/8

Dates

Submitted
2022-10-21
Conference held

Software

Repository URL
http://space.bas.bg/ses/archive/ses%202022_dokladi/3_Remote%20Sensing/9_Dimitrova.pdf
Development Status
Active

References

  • Page, J, Hinshaw D, McKay B (26 February 2021). "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Retrieved 27 February 2021.
  • Islam, MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients". PLOS ONE. 16 (4): e0249788. Bibcode:2021PLoSO..1649788I. doi:10.1371/journal.pone.0249788. PMC 8023501. PMID 33822812.
  • Saniasiaya, J, Islam MA (April 2021). "Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients". The Laryngoscope. 131 (4): 865–878. doi:10.1002/lary.29286. ISSN 0023-852X. PMC 7753439. PMID 33219539.
  • Agyeman, AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (August 2020). "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis". Mayo Clin. Proc. 95 (8): 1621–1631. doi:10.1016/j.mayocp.2020.05.030. PMC 7275152. PMID 32753137.
  • Oran, DP, Topol EJ (January 2021). "The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review". Annals of Internal Medicine. 174 (5): M20-6976. doi:10.7326/M20-6976. PMC 7839426. PMID 33481642.
  • Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)". U.S. Centers for Disease Control and Prevention (CDC). 6 April 2020. Archived from the original on 2 March 2020. Retrieved 19 April 2020.